These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 4113870)
21. Idiotype-specific T lymphocytes. I. Regulation of antibody production by idiotype-specific H-2-restricted T lymphocytes. Yamamoto H; Bitoh S; Torii M; Fujimoto S J Immunol; 1983 Mar; 130(3):1038-42. PubMed ID: 6185567 [TBL] [Abstract][Full Text] [Related]
22. Immunoglobulins in intact, immunized, and contaminated axenic mice: study of serum IgA. Benveniste J; Lespinats G; Adam C; Salomon JC J Immunol; 1971 Dec; 107(6):1647-55. PubMed ID: 4330458 [No Abstract] [Full Text] [Related]
23. Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315. Eisen HN; Simms ES; Potter M Biochemistry; 1968 Nov; 7(11):4126-34. PubMed ID: 4177521 [No Abstract] [Full Text] [Related]
24. Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes. Russell JH; Hale AH; Ginns LC; Eisen HN Proc Natl Acad Sci U S A; 1978 Jan; 75(1):441-5. PubMed ID: 75547 [TBL] [Abstract][Full Text] [Related]
25. Hapten binding studies on mouse IgA myeloma proteins with antibody activity. Sher A; Tarikas H J Immunol; 1971 May; 106(5):1227-33. PubMed ID: 4995750 [No Abstract] [Full Text] [Related]
26. The susceptibility of the mouse immunoglobulin subclasses to suppression by high doses of antigen. Hay FC; Torrigiani G Eur J Immunol; 1974 Jan; 4(1):5-10. PubMed ID: 4855103 [No Abstract] [Full Text] [Related]
27. Expression of various tumor-specific antigens in polyoma virus-induced tumors. Ting CC; Lavrin DH; Takemoto KK; Ting RC; Herberman RB Cancer Res; 1972 Jan; 32(1):1-6. PubMed ID: 4332472 [No Abstract] [Full Text] [Related]
28. Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline. Potter M; Lieberman R J Exp Med; 1970 Oct; 132(4):737-51. PubMed ID: 4101363 [TBL] [Abstract][Full Text] [Related]
29. A monoclonal antiidiotypic antibody to MOPC 315 IgA inhibits the growth of MOPC 315 myeloma cells in vitro. Mahony J; Bose A; Cowdrey D; Nusair T; Lei M; Harris J; Marks A; Baumal R J Immunol; 1981 Jan; 126(1):113-7. PubMed ID: 7451962 [TBL] [Abstract][Full Text] [Related]
30. A method for demonstrating mono- and oligomeric units of IgA myeloma proteins in the mouse. Jaquet H; Burkhard M; Herzig AL J Immunol Methods; 1974 Mar; 4(2):359-68. PubMed ID: 4207930 [No Abstract] [Full Text] [Related]
31. Amino acid sequence of the light chain from a mouse myeloma protein with anti-hapten activity: evidence for a third type of light chain. Schulenburg EP; Simms ES; Lynch RG; Bradshaw RA; Eisen HN Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2623-6. PubMed ID: 5288236 [TBL] [Abstract][Full Text] [Related]
32. Specific isolation and characterization of antibody directed to binding site antigenic determinants. Claflin JL; Davie JM J Immunol; 1975 Jan; 114(1 Pt 1):70-5. PubMed ID: 46246 [TBL] [Abstract][Full Text] [Related]
33. Antiserum against tyrosinase from mouse melanoma. Ohtaki N; Miyazaki K J Invest Dermatol; 1972 Apr; 58(4):238-41. PubMed ID: 4623203 [No Abstract] [Full Text] [Related]
34. Effect of anti-immunoglobulin antisera on homograft rejection in mice. Manning DD; Jutila JW Nat New Biol; 1972 May; 237(71):58-9. PubMed ID: 4555684 [No Abstract] [Full Text] [Related]